The Saban Research Institute, Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.
Cancer Lett. 2010 Mar 28;289(2):188-94. doi: 10.1016/j.canlet.2009.08.015. Epub 2009 Sep 3.
The geldanamycin derivative, 17-allylamino-17-demethoxygeldanamycin (17-AAG), binds to the amino-terminal ATP binding pocket of the 90 kDa heat shock protein (Hsp-90) and inhibits this chaperone from stabilizing client proteins involved with the malignant phenotype. We examined the effects of a combined modality protocol involving photodynamic therapy (PDT) and 17-AAG in mouse mammary carcinoma cells and tumors. PDT increased the expression of the anti-apoptotic and pro-angiogenic proteins survivin, Akt, HIF-1alpha, MMP-2 and VEGF in tumor tissue and this expression decreased significantly when 17-AAG was included in the treatment regimen. Tumor bearing mice treated with PDT and 17-AAG had improved long-term tumoricidal responses when compared with individual treatment protocols. We conclude that Hsp-90 plays an active role in modulating tumor responsiveness following PDT and targeting Hsp-90 with 17-AAG enhances the therapeutic effectiveness of PDT.
格尔德霉素衍生物 17-烯丙氨基-17-去甲氧基格尔德霉素(17-AAG)与 90kDa 热休克蛋白(Hsp-90)的氨基末端 ATP 结合口袋结合,并抑制该伴侣蛋白稳定与恶性表型相关的客户蛋白。我们研究了包括光动力疗法(PDT)和 17-AAG 的联合治疗方案在小鼠乳腺癌细胞和肿瘤中的作用。PDT 增加了肿瘤组织中抗凋亡和促血管生成蛋白生存素、Akt、HIF-1α、MMP-2 和 VEGF 的表达,而当 17-AAG 包含在治疗方案中时,这种表达显著下降。与单独的治疗方案相比,接受 PDT 和 17-AAG 治疗的荷瘤小鼠具有更好的长期抗肿瘤反应。我们得出结论,Hsp-90 在调节 PDT 后的肿瘤反应中起积极作用,用 17-AAG 靶向 Hsp-90 可增强 PDT 的治疗效果。